Menu

#Pharma

18 posts

Feed·
17 of 18 posts
0Read More

Denmark’s Leo Pharma Delays IPO Plans Beyond 2026, CEO Says

Bloomberg Markets·Sanne Wass·2 days ago
#MiDFzKOG
#bloomberg#business#pharma#delaying#plans

Leo Pharma A/S is delaying plans for an initial public offering beyond 2026, pushing back a listing it had previously targeted for this year.

15s
Astellas employee to be released from China prison in December
🖼️
0Read More

Astellas employee to be released from China prison in December

Latest articles - The Japan Times·10 days ago
#Uf9xhFBl
#japantimes#employee#japanese#china#astellas

Beijing had accused the Japanese citizen of espionage by providing China-related information to an intelligence agency but had not provided further details.

15s
Royalty Pharma plc (RPRX) Q3 2026 Earnings Call Transcript
🖼️
0Read More

Royalty Pharma plc (RPRX) Q3 2026 Earnings Call Transcript

All Articles on Seeking Alpha·14 days ago
#sXT3Swyd
#seekingalpha#research#call#royalty#pharma

Royalty Pharma plc (RPRX) Q3 2026 Earnings Call November 4, 2026 8:00 AM ESTCompany ParticipantsGeorge Grofik - Senior VP and Head of Investor Relations...

15s
Why AI on Deviations Needs One Batch Record, Not Three Systems
📰
0Read More

Why AI on Deviations Needs One Batch Record, Not Three Systems

DEV Community: database·Siddhi LLC·19 days ago
#sd7ZUADr
#devtodatabase#devto#dev#record#batch

Why AI on deviations needs one batch record and one audit trail, not three systems, and what AI agents do and don't do in Atto Pharma.

15s
drug-pipeline-mcp: Open-source pharmaceutical R&D intelligence
🖼️
0Read More

drug-pipeline-mcp: Open-source pharmaceutical R&D intelligence

DEV Community·DasClown·6 months ago
#rQpWkQIF
#mcp#pharma#python#api#pipeline

From Dev.to - python: drug-pipeline-mcp: Open-source pharmaceutical R&D intelligence

15s
UCB pays up to $2.2bn for Candid Therapeutics, doubling down on T-cell engagers in autoimmune disease
🖼️
0Read More

UCB pays up to $2.2bn for Candid Therapeutics, doubling down on T-cell engagers in autoimmune disease

TNW | Health-Tech·Ana-Maria Stanciuc·7 months ago
#lJWJOYir
#facebook#twitter#flipboard#mail#linkedin

The Belgian pharma is buying a two-year-old San Diego biotech for $2bn upfront, the second TCE bet it has placed in months. The thesis: B-cell killers built for cancer can rewire how autoimmune diseases are treated. Candid Therapeutics is two years old.…

15s
Colorado to get $75 million from opioid settlement with Purdue Pharma
🖼️
0Read More

Colorado to get $75 million from opioid settlement with Purdue Pharma

Colorado Springs Gazette·Marissa Ventrelli [email protected]·7 months ago
#pPr5bAxa

A $7.4 billion settlement reached with the pharmaceutical company Purdue Pharma and the Sackler family — its owners — is now legally effective a decade after attorneys general from multiple states launched an investigation and seven years after Colorado…

15s
Sun Pharma to acquire Organon for $11.75 bn: How this will expand US footprint, why the timing is significant
📰
0Read More

Sun Pharma to acquire Organon for $11.75 bn: How this will expand US footprint, why the timing is significant

The Indian Express·George Mathew·7 months ago
#DdTvgjZo

The deal comes at a time when the Donald Trump administration is progressively disincentivising foreign pharma manufacturers, especially makers of non-generics and those shopping in drugs from other manufacturing hubs

15s
0Read More

Shaping the future of Japan’s pharmaceutical operations

McKinsey Insights & Publications·7 months ago
#vPaHRkKt
#mckinsey#japan#pharma#industry#global

Japan’s pharma industry, a global innovation leader, faces strain from shifting demand, supply vulnerabilities, and digital disruption. Eight priorities can position it to lead in operations.

15s